Karsh J, Harley J B, Goldstein R, Lazarovits A I
Rheumatic Disease Unit, Ottawa General Hospital, University of Ottawa, Ontario, Canada.
Clin Exp Immunol. 1993 Jan;91(1):103-9. doi: 10.1111/j.1365-2249.1993.tb03362.x.
To test the hypothesis that the Ro/SSA autoantigen can be recognized as antigenic by the human immune system, lymphocytes obtained from normal volunteers were used in in vitro assays evaluating the ability of Ro/SSA (mol. wt 60 kD) to induce B and/or T cell responses. Bovine Ro/SSA strongly inhibited the autologous mixed lymphocyte reaction in a dose-dependent manner without similar effects on concurrently performed allogeneic mixed lymphocyte reactions or T cell proliferation induced by phytohaemagglutinin. Using three colour FACS analysis, Ro/SSA was found to decrease the percentage of CD4+CD45+RA+ T cells in the proliferative, S+(G2+M), phase of the cell cycle. Associated with the decrease in the percentage of suppressor-inducer cells, was the finding that Ro/SSA was able to augment RF production in pokeweed mitogen stimulated cultures of peripheral blood lymphocytes.
为了验证Ro/SSA自身抗原可被人类免疫系统识别为抗原这一假说,从正常志愿者获取的淋巴细胞被用于体外试验,以评估Ro/SSA(分子量60 kD)诱导B细胞和/或T细胞反应的能力。牛Ro/SSA以剂量依赖方式强烈抑制自体混合淋巴细胞反应,而对同时进行的同种异体混合淋巴细胞反应或植物血凝素诱导的T细胞增殖没有类似影响。使用三色荧光激活细胞分选分析发现,Ro/SSA在细胞周期的增殖期S+(G2+M)可降低CD4+CD45+RA+ T细胞的百分比。与抑制诱导细胞百分比降低相关的是,发现Ro/SSA能够增强外周血淋巴细胞在商陆有丝分裂原刺激培养物中的类风湿因子产生。